The University of Texas MD Anderson Cancer Center announced an agreement to become a Women’s Cancer Partner with the Union for International Cancer Control, marking a significant collaboration to improve breast and cervical cancer care worldwide.
Kevin Holcomb will join Northwell Health as chair of the Department of Obstetrics and Gynecology at North Shore University Hospital in Manhasset, Long Island Jewish Medical Center in New Hyde Park, and The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in Uniondale.
Meagan O. O’Neill was named executive director of the Association of Cancer Care Centers. O’Neill will serve as the third executive director and the first woman in the role.
Sir Paul Nurse is the recipient of the 26th Herbert and Maxine Block Memorial Lectureship Award for Distinguished Achievement in Cancer. A geneticist and cell biologist who shared the 2001 Nobel Prize in Physiology or Medicine, Nurse is founding director and chief executive officer of the Francis Crick Institute in London.
NCI has awarded researchers at Washington University School of Medicine in St. Louis a Specialized Programs of Research Excellence grant to spur new strategies to prevent and treat endometrial cancer.
Four NCI-designated cancer centers—Dana-Farber Cancer Institute, Fred Hutch Cancer Center, Memorial Sloan Kettering Cancer Center, and The Sidney Kimmel Comprehensive Cancer Center and Whiting School of Engineering at Johns Hopkins—have joined together and secured funding from AWS, Deloitte, Microsoft, and NVIDIA, to create the Cancer AI Alliance.
Qure.ai has announced the completion of a $65 million Series D funding round. The investment will expedite expansion into the U.S. market and other countries, increase investment in foundational AI models, and enable complementary med-tech company acquisitions.
Researchers from the UCLA Health Jonsson Comprehensive Cancer Center were awarded a $3 million grant from NIH to improve follow-up care for colorectal cancer screening in underserved populations.
The Robert J. Kleberg Jr. and Helen C. Kleberg Foundation awarded a $1 million grant to support research at Vanderbilt aimed at dramatically expanding the efficacy of immunotherapy for colorectal cancer.
Scientists at the University of Oxford are designing OvarianVax, a vaccine which teaches the immune system to recognise and attack the earliest stages of ovarian cancer. The team will receive up to £600,000 (approximately US$800,000) for the study over the next three years to support lab research into the vaccine.
